Xiaowen specialises in M&A transactions and corporate law structuring of national and international companies. She has particular expertise in the area of corporate transactions and structuring in the healthcare sector, is familiar with the specifics of the highly regulated healthcare sector and has excellent networks there.

 

Of particular note are the approximately 60 M&A transactions for the creation of medical care centre groups as well as nine clinic transactions which underline her successful track record for ongoing advice to various corporate groups. On the product side, Xiaowen is also an experienced legal adviser with medtech, biotech and pharmaceutical transactions, including digital health investments. As a native Chinese speaker and member of the China Group, Xiaowen also advises Chinese companies and investors on outbound activities in Germany and Europe.

显示完整简历 隐藏完整简历

最新新闻和观点

技术、媒体与通信 (TMC)

Completing sale of managed service provider Hentsū

2021年3月4日

作者

点击此处了解更多
公司/并购与资本市场

Advising WuXi AppTec on acquisition of OXGENE to strengthen cell and gene therapy service

2021年3月4日

作者

点击此处了解更多
pen close-up
公司/并购与资本市场

Taylor Wessing advises Bloomreach on acquisition of Exponea

2021年3月2日

作者

点击此处了解更多
公司/并购与资本市场

Advising Jagex, one of the UK’s largest video game developers and publishers, on its sale

2021年3月1日

作者

点击此处了解更多

与我会面: